Pharmacological heterogeneity limits antidepressant studyBMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7409.289-a (Published 31 July 2003) Cite this as: BMJ 2003;327:289
- Anthony S Hale, professor of psychiatry ([email protected])
- University of Kent, Canterbury CT2 7NZ
EDITOR—MacGillivray et al potentially make a huge contribution to the understanding of the relative utility of selective serotonin reuptake inhibitors and older antidepressants in the treatment of depression in primary care.1 However, the usefulness of their meta-analysis is limited by the original data, as is so often the case.
These results …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial